|
2020 Journal Article β-lactam antibiotic versus combined β-lactam antibiotic and single-daily dosing regimens of aminoglycosides for the treatment of serious infections: a meta-analysisHeffernan, Aaron James, Sime, Fekade Bruck, Sun, Jing, Lipman, Jeffrey, Kumar, Anand, Andrews, Katherine, Ellwood, David, Grimwood, Keith and Roberts, Jason (2020). β-lactam antibiotic versus combined β-lactam antibiotic and single-daily dosing regimens of aminoglycosides for the treatment of serious infections: a meta-analysis. International Journal of Antimicrobial Agents, 55 (3) 105839, 105839. doi: 10.1016/j.ijantimicag.2019.10.020 |
|
2020 Journal Article Antimicrobial de-escalation is part of appropriate antibiotic usage in ICUTimsit, Jean-Francois, Lipman, Jeffrey and Bassetti, Matteo (2020). Antimicrobial de-escalation is part of appropriate antibiotic usage in ICU. Intensive Care Medicine, 46 (5), 1039-1042. doi: 10.1007/s00134-020-05951-5 |
|
2020 Journal Article β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically illWong, Gloria, Taccone, Fabio, Villois, Paola, Scheetz, Marc H., Rhodes, Nathaniel J., Briscoe, Scott, McWhinney, Brett, Nunez-Nunez, Maria, Ungerer, Jacobus, Lipman, Jeffrey and Roberts, Jason A. (2020). β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill. Journal of Antimicrobial Chemotherapy, 75 (2), 429-433. doi: 10.1093/jac/dkz437 |
|
2020 Journal Article Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?Koulenti, Despoina, Arvaniti, Kostoula, Judd, Mathew, Lalos, Natasha, Tjoeng, Iona, Xu, Elena, Armaganidis, Apostolos and Lipman, Jeffrey (2020). Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?. Antibiotics, 9 (2) 51, 51. doi: 10.3390/antibiotics9020051 |
|
2020 Journal Article Emerging treatment options for infections by multidrug-resistant gram-positive microorganismsKoulenti, Despoina, Xu, Elena, Song, Andrew, Mok, Isaac Yin Sum , Karageorgopoulos, Drosos E., Armaganidis, Apostolos, Tsiodras, Sotirios and Lipman, Jeffrey (2020). Emerging treatment options for infections by multidrug-resistant gram-positive microorganisms. Microorganisms, 8 (2) 191, 1-40. doi: 10.3390/microorganisms8020191 |
|
2020 Journal Article Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaecheiRoberts, Leah W., Harris, Patrick N. A., Forde, Brian M., Ben Zakour, Nouri L., Catchpoole, Elizabeth, Stanton-Cook, Mitchell, Phan, Minh-Duy, Sidjabat, Hanna E., Bergh, Haakon, Heney, Claire, Gawthorne, Jayde A., Lipman, Jeffrey, Allworth, Anthony, Chan, Kok-Gan, Chong, Teik Min, Yin, Wai-Fong, Schembri, Mark A., Paterson, David L. and Beatson, Scott A. (2020). Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei. Nature Communications, 11 (1) 466, 466. doi: 10.1038/s41467-019-14139-5 |
|
2020 Journal Article Erratum to ‘When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit’ [Clin Microbiol Infect 26 (1) (January 2020) 35–40](S1198743X19303969)(10.1016/j.cmi.2019.07.007)Denny, K. J., De Waele, J., Laupland, K. B., Harris, P. N.A. and Lipman, J. (2020). Erratum to ‘When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit’ [Clin Microbiol Infect 26 (1) (January 2020) 35–40](S1198743X19303969)(10.1016/j.cmi.2019.07.007). Clinical Microbiology and Infection, 26 (6), 801-801. doi: 10.1016/j.cmi.2020.01.016 |
|
2020 Journal Article Antimicrobial-associated harm in critical care: a narrative reviewArulkumaran, Nishkantha, Routledge, Matthew, Schlebusch, Sanmarié, Lipman, Jeffrey and Conway Morris, Andrew (2020). Antimicrobial-associated harm in critical care: a narrative review. Intensive Care Medicine, 46 (2), 225-235. doi: 10.1007/s00134-020-05929-3 |
|
2020 Journal Article Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsisFujii, Motoki, Karumai, Toshiyuki, Yamamoto, Ryohei, Kobayashi, Eri, Ogawa, Kenta, Tounai, Mayuko, Lipman, Jeffrey and Hayashi, Yoshiro (2020). Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis. Expert Opinion on Drug Metabolism and Toxicology, 16 (5), 1-16. doi: 10.1080/17425255.2020.1750597 |
|
2020 Journal Article Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populationsXie, Jiao, Roberts, Jason A., Lipman, Jeffrey, Cai, Yan, Wang, Haitao, Zhao, Nuannuan, Xu, Xiaona, Yang, Shan, Li, Youjia and Zhang, Kanghuai (2020). Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations. International Journal of Antimicrobial Agents, 55 (6) 105943, 105943. doi: 10.1016/j.ijantimicag.2020.105943 |
|
2020 Journal Article When not to start antibiotics: avoiding antibiotic overuse in the intensive care unitDenny, K. J., De Waele, J., Laupland, K. B., Harris, P. N. A. and Lipman, J. (2020). When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit. Clinical Microbiology and Infection, 26 (1), 35-40. doi: 10.1016/j.cmi.2019.07.007 |
|
2020 Journal Article Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patientsYadav, Rajbharan, Bergen, Phillip J., Rogers, Kate E., Kirkpatrick, Carl M. J., Wallis, Steven C., Huang, Yuling, Bulitta, Jürgen B., Paterson, David L., Lipman, Jeffrey, Nation, Roger L., Roberts, Jason A. and Landersdorfer, Cornelia B. (2020). Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients. Antimicrobial Agents and Chemotherapy, 64 (1) e01679-19. doi: 10.1128/aac.01679-19 |
|
2020 Journal Article A population pharmacokinetic model-guided evaluation of ceftolozane/tazobactam dosing in critically ill patients undergoing continuous venovenous hemodiafiltrationSime, Fekade B., Lassig-Smith, Melissa, Starr, Therese, Stuart, Janine, Pandey, Saurabh, Parker, Suzanne L., Wallis, Steven C., Lipman, Jeffrey and Roberts, Jason A. (2020). A population pharmacokinetic model-guided evaluation of ceftolozane/tazobactam dosing in critically ill patients undergoing continuous venovenous hemodiafiltration. Antimicrobial Agents and Chemotherapy, 64 (1) e01655. doi: 10.1128/aac.01655-19 |
|
2019 Journal Article Antimicrobial resistance: we must pursue a collaborative, global approach and use a “one health” approachLonsdale, Dagan O. and Lipman, Jeffrey (2019). Antimicrobial resistance: we must pursue a collaborative, global approach and use a “one health” approach. Antibiotics, 8 (4) 237, 237. doi: 10.3390/antibiotics8040237 |
|
2019 Journal Article Pharmacokinetics of enteric coated mycophenolate sodium in lupus nephritis (POEMSLUN)Ranganathan, Dwarakanathan, Abdul-Aziz, Mohd H., John, George T., McWhinney, Brett C., Fassett, Robert G., Healy, Helen, Kubler, Paul, Lim, Aaron, Lipman, Jeffrey, Purvey, Megan, Roberts, Matthew, Reyaldeen, Reza, Ungerer, Jacobus and Roberts, Jason A. (2019). Pharmacokinetics of enteric coated mycophenolate sodium in lupus nephritis (POEMSLUN). Therapeutic Drug Monitoring, 41 (6), 703-713. doi: 10.1097/ftd.0000000000000658 |
|
2019 Journal Article Survey of critical care practice in Australian and New Zealand burn referral centresHolley, Anthony D., Reade, Michael C., Lipman, Jeffrey, Delaney, Anthony, Udy, Andrew, Lee, Richard, Litton, Edward, Cheung, Winston, Turner, Andrew, Garside, Tessa, Macken, Lewis, Reddi, Benjamin, Kol, Mark, Kazemi, Alex, Shah, Asim, Townsend, Shane and Cohen, Jeremy (2019). Survey of critical care practice in Australian and New Zealand burn referral centres. Critical Care and Resuscitation, 21 (4), 303-304. |
|
2019 Journal Article Saturable elimination of piperacillin in critically ill patients: implications for continuous infusionDhaese, S.A.M., Colin, P., Willems, H., Heffernan, A., Gadeyne, B., Van Vooren, S., Depuydt, P., Hoste, E., Stove, V., Verstraete, A.G., Lipman, J., Roberts, J.A. and De Waele, J.J. (2019). Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion. International Journal of Antimicrobial Agents, 54 (6), 741-749. doi: 10.1016/j.ijantimicag.2019.08.024 |
|
2019 Journal Article A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic studyParker, Suzanne L., Pandey, Saurabh, Sime, Fekade B., Lipman, Jeffrey, Roberts, Jason A. and Wallis, Steven C. (2019). A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic study. Analytical and Bioanalytical Chemistry, 411 (29), 7831-7840. doi: 10.1007/s00216-019-02184-4 |
|
2019 Journal Article Elaboration of consensus clinical endpoints to evaluate antimicrobial treatment efficacy in future hospital-acquired/ventilator-associated bacterial pneumonia clinical trialsWeiss, Emmanuel, Zahar, Jean-Ralph, Alder, Jeff, Asehnoune, Karim, Bassetti, Matteo, Bonten, Marc J. M, Chastre, Jean, De Waele, Jan, Dimopoulos, George, Eggimann, Philippe, Engelhardt, Marc, Ewig, Santiago, Kollef, Marin, Lipman, Jeffrey, Luna, Carlos, Martin-Loeches, Ignacio, Pagani, Leonardo, Palmer, Lucy B, Papazian, Laurent, Poulakou, Garyphallia, Prokocimer, Philippe, Rello, Jordi, Rex, John H, Shorr, Andrew F, Talbot, George H, Thamlikitkul, Visanu, Torres, Antoni, Wunderink, Richard G and Timsit, Jean-François (2019). Elaboration of consensus clinical endpoints to evaluate antimicrobial treatment efficacy in future hospital-acquired/ventilator-associated bacterial pneumonia clinical trials. Clinical Infectious Diseases, 69 (11), 1912-1918. doi: 10.1093/cid/ciz093 |
|
2019 Journal Article Development and validation of LC-MS/MS methods to measure tobramycin and lincomycin in plasma, microdialysis fluid and urine: application to a pilot pharmacokinetic research studyPandey, Saurabh, Dhanani, Jayesh, Lipman, Jeffrey, Roberts, Jason A., Wallis, Steve C. and Parker, Suzanne L. (2019). Development and validation of LC-MS/MS methods to measure tobramycin and lincomycin in plasma, microdialysis fluid and urine: application to a pilot pharmacokinetic research study. Clinical Chemistry and Laboratory Medicine, 58 (2), 274-284. doi: 10.1515/cclm-2019-0780 |
